Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial

Autor: Branch, Kelley R.H., Probstfield, Jeffrey L., Bosch, Jackie, Bhatt, Deepak L., Maggioni, Aldo P., Muehlhofer, Eva, Avezum, Alvaro, Widimsky, Petr, Connolly, Stuart J., Yi, Quilong, Shestakovska, Olga, Yusuf, Salim, Eikelboom, John W.
Zdroj: In American Heart Journal April 2023 258:60-68
Databáze: ScienceDirect
Externí odkaz: